ICAM1 Gene Malaria Cerebral Susceptibility to NGS Genetic DNA Test
Introduction
The ICAM1 Gene Malaria Cerebral Susceptibility to NGS Genetic DNA Test is a cutting-edge genetic test designed to assess an individual’s susceptibility to severe malaria, particularly cerebral malaria, through the analysis of the ICAM1 gene. Understanding your genetic predisposition is crucial in managing and preventing severe complications associated with malaria.
What the Test Measures
This test evaluates variations in the ICAM1 gene that may indicate a higher risk of developing cerebral malaria. By leveraging Next-Generation Sequencing (NGS) technology, we can provide precise insights into your genetic makeup.
Who Should Consider This Test
Individuals with a family history of severe malaria or those who have experienced recurrent malaria infections should consider this test. Symptoms such as severe headaches, confusion, or seizures during malaria episodes may also warrant testing.
Benefits of Taking the Test
- Identifies genetic risk factors for cerebral malaria.
- Enables personalized treatment plans and preventive measures.
- Provides peace of mind for individuals at risk.
- Facilitates early intervention and monitoring strategies.
Understanding Your Results
Results will indicate whether you carry genetic variations associated with increased susceptibility to cerebral malaria. Your healthcare provider will guide you through the implications of your results and recommend appropriate follow-up actions.
Pricing Information
Test Name | Discount Price | Regular Price |
---|---|---|
ICAM1 Gene Malaria Cerebral Susceptibility to NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Branches and Booking
We have branches across Kenya, making it convenient for you to access our services. To book the ICAM1 Gene Malaria Cerebral Susceptibility to NGS Genetic DNA Test, please call or WhatsApp us at +254711564616. Early diagnosis can lead to better health outcomes, so don’t hesitate to take this important step towards understanding your health!